Drug Trial Radar · NCT04384484
Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Last checked: Nov 20, 2026Latest source record: Apr 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
440
Actual
Start
Sep 16, 2020
Primary completion
Mar 31, 2026
Study completion Jun 30, 2028
Sponsor
- Lead sponsor
- ADC Therapeutics S.A.Industry
- Sponsor type
- Industry
- First posted
- May 12, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy of loncastuximab tesirine (ADCT-402) combined with rituximab compared to standard immunochemotherapy.
Conditions
- Relapsed Diffuse Large B-Cell Lymphoma
- Refractory Diffuse Large B-Cell Lymphoma
Interventions
Loncastuximab TesirineDrug
Intravenous Infusion
RituximabDrug
Intravenous Infusion
GemcitabineDrug
Intravenous Infusion
OxaliplatinDrug
Intravenous Infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-free Survival (PFS)Time frame: Up to 4 years
Locations
144 sites in 21 countries. Site status is shown where the registry gives one.
University of California San Diego Moores Cancer Center
La Jolla, California
Redlands Community Hospital
Redlands, California
The Oncology Institute of Hope and Innovation
Whittier, California
Baptist MD Anderson Cancer Center
Jacksonville, Florida
UnityPoint Health - Iowa Oncology Research Association (IORA)
Des Moines, Iowa
Norton Cancer Institute
Louisville, Kentucky
Comprehensive Cancer Centers of Nevada - Henderson
Las Vegas, Nevada
Kaiser Permanente Interstate Medical Office Central
Portland, Oregon
Hollings Cancer Center
Charleston, South Carolina
Virginia Cancer Specialists
Gainesville, Virginia
Medical College of Wisconsin Cancer Center Clinical Trials Office
Milwaukee, Wisconsin
Clinica Adventista Belgrano
Belgrano, Buenos Aires, Argentina
Clínica de Nefrología, Urología y Enfermedades Cardiovasculares S.A.
Santa Fe, Buenos Aires, Argentina
Instituto Médico Especializado Alexander Fleming
Buenos Aires, Distrito Federal, Argentina
Grupo Gamma - Hospital Privado Rosario
Rosario, Santa Fe Province, Argentina
Algemeen Ziekenhuis Sint-Jan Brugge-Oostende - Campus Sint-Jan
Bruges, Belgium
Cliniques Universitaires Saint-Luc
Brussels, Belgium
Centre Hospitalier Universitaire Universite Catholique de Louvain
Namur, Belgium
Algemeen Ziekenhuis Delta - Campus Rumbeke
Roeselare, Belgium
Hospital do Câncer
Rio de Janeiro, Brazil
Hemomed Instituto de Oncologia e Hematologia
São Paulo, Brazil
A Beneficência Portuguesa de São Paulo - Unidade Mirante
São Paulo, Brazil
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
São Paulo, Brazil
Hospital Israelita Albert Einstein
São Paulo, Brazil
Hospital Santa Marcelina
São Paulo, Brazil
Hospital Erasto Gaertner - Liga Paranaense de Combate ao Câncer
Curitiba, Paraná, Brazil
Hospital Moinhos de Vento
Porto Alegre, Rio Grande do Sul, Brazil
Hospital de Clínicas de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil
Hospital Mãe de Deus - Centro Integrado de Oncologia
Porto Alegre, Rio Grande do Sul, Brazil
Cross Cancer Institute
Edmonton, Canada
Research Institute of the McGill University Health Centre
Montreal, Canada
Hôpital Fleurimont
Sherbrooke, Canada
Centro de Estudios Clínicos SAGA
Santiago, Santiago Metropolitan, Chile
Instituto Oncológico Fundación Arturo López Pérez
Santiago, Santiago Metropolitan, Chile
CeCim - Centro de Estudios Clínicos e Investigaciones Médicas
Santiago, Santiago Metropolitan, Chile
Chongqing University Cancer Hospital - Chongqing Cancer Hospital
Chongqing, China
Huizhou Municipal Central Hospital
Huizhou, China
The First Affiliated Hospital of Nanchang University
Nanchang, China
Institute of Hematology and Blood Diseases Hospital of CAMS - PUMC
Tianjin, China
Wuhan Union Hospital
Wuhan, China
Showing 40 of 144 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.